Regulatory Revisions, Cut Backs At Big Pharma, Provide Spark For China Innovation - BayHelix Annual Meeting

SHANGHAI - BayHelix, a leading life sciences professional society for business leaders of Chinese origin, held its eighth annual conference in Shanghai April 10, and the day-long symposium trumpeted the opportunities for domestic pharma innovation brought on by China's healthcare reform and regulatory enhancements